Jeryl Hilleman

Ms. Jeryl L.
Hilleman is an Independent Director at SI-BONE, Inc., a Chairman at Omada Health, Inc., an Independent Director at NovoCure Ltd., a Member at Aspen Global Leadership Network and a Member at Henry Crown Fellowship Program.
She is on the Board of Directors at SI-BONE, Inc., NovoCure Ltd. and GeoHazards International.
Ms. Hilleman was previously employed as an Independent Director by Cutera, Inc., an Independent Director by HilleVax, Inc., an Independent Director by Minerva Neurosciences, Inc., a Chief Financial Officer by Intersect ENT, Inc., a CFO, Secretary, CAO & Head-Investor Relations by OCERA Therapeutics LLC, a Chief Financial Officer by Amyris, Inc., an Independent Director by XenoPort, Inc., a Chief Financial Officer & Executive Vice President by Symyx Technologies, Inc., a Chief Financial Officer & Vice President-Finance by Geron Corp., and a Chief Financial Officer & Vice President-Finance by Cytel Corp.
She also served on the board at Talis Biomedical Corp.
and Cardiva Medical, Inc. She received her undergraduate degree from Brown University and an MBA from The Wharton School of the University of Pennsylvania.